Results 261 to 270 of about 152,498 (307)

Class I Histone Deacetylase Inhibitor Valproic Acid Reverses Cognitive Deficits in a Mouse Model of Septic Encephalopathy

Neurochemical Research, 2013
Jing Wu, Lin Dong, Mingqiang Zhang, M. Jia, Guangfen Zhang, Li-li Qiu, Muhuo Ji, Jian-Jun Yang   +7 more
semanticscholar   +1 more source

A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine

Annals of Oncology, 2004
Thomas A Macek, Mark J Ratain, H L Kindler   +2 more
exaly  

Zinc binding groups for histone deacetylase inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry, 2018
Qixiao Jiang, Weiguo Song
exaly  

Histone deacetylase inhibitors

2006
BELVEDERE SANDRO, HAMBLETT CHRISTOPHER LAURENCE, MILLER THOMAS A, WITTER DAVID J, YAN JIAMING   +4 more
openaire   +6 more sources

Romidepsin: a novel histone deacetylase inhibitor for cancer

Expert Opinion on Investigational Drugs, 2011
Gregory A Otterson, Erin M Bertino
exaly  

Histone deacetylase inhibitors in cancer therapy

Expert Opinion on Investigational Drugs, 2007
Ricky W Johnstone
exaly  

Inhibitors of histone deacetylase

2003
DELORME DANIEL, WOO SOON HYUNG, VAISBURG ARKADII, MORADEI OSCAR, LEIT SILVANA, RAEPPEL STEPHANE, FRECHETTE SYLVIE, BOUCHAIN GILIANE   +7 more
openaire   +15 more sources

Histone deacetylase inhibitors: from target to clinical trials

Expert Opinion on Investigational Drugs, 2002
William Kelly, Paul Marks, Owen A O’Connor   +2 more
exaly  

Inhibitors of Histone Deacetylase

2014
HOLSON EDWARD, WAGNER FLORENCE FEVRIER, WEIWER MICHEL, TSAI LI-HUEI, HAGGARTY STEPHEN, ZHANG YAN-LING   +5 more
openaire   +10 more sources

Histone deacetylase inhibitors in lymphoma and solid malignancies

Expert Review of Anticancer Therapy, 2008
Mark Bishton, Ricky W Johnstone
exaly